Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $598.19 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EISAI INC. | $127.59 | 1 | $0 (2022) |
| Incyte Corporation | $125.00 | 1 | $0 (2021) |
| Amgen Inc. | $124.99 | 1 | $0 (2022) |
| BTG International, Inc. | $122.40 | 2 | $0 (2023) |
| Novo Nordisk Inc | $98.21 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $122.40 | 2 | BTG International, Inc. ($122.40) |
| 2022 | $350.79 | 3 | EISAI INC. ($127.59) |
| 2021 | $125.00 | 1 | Incyte Corporation ($125.00) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/16/2023 | BTG International, Inc. | VORAXAZE (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 06/29/2023 | BTG International, Inc. | VORAXAZE (Drug) | Food and Beverage | In-kind items and services | $97.62 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 06/09/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $127.59 | General |
| Category: Oncology | ||||||
| 05/18/2022 | Amgen Inc. | Nplate (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Hematology | ||||||
| 04/28/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $98.21 | General |
| 10/04/2021 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Hematology/Oncology | ||||||
About Anna Evans
Anna Evans is a Pediatric Hematology-Oncology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1023277589.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anna Evans has received a total of $598.19 in payments from pharmaceutical and medical device companies, with $122.40 received in 2023. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($598.19).
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Los Angeles, CA
- Active Since 06/09/2008
- Last Updated 01/20/2017
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1023277589
Products in Payments
- Lenvima (Drug) $127.59
- JAKAFI (Drug) $125.00
- Nplate (Biological) $124.99
- VORAXAZE (Drug) $122.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Los Angeles
Jan Van Tornout, Md, MD
Pediatric Hematology-Oncology — Payments: $470,897
Noah Federman, M.d, M.D
Pediatric Hematology-Oncology — Payments: $353,544
Thomas Coates, Md, MD
Pediatric Hematology-Oncology — Payments: $158,777
Dr. Andrew Dietz, Md, Ms, MD, MS
Pediatric Hematology-Oncology — Payments: $88,475
Mr. Paul Gaynon, M.d, M.D
Pediatric Hematology-Oncology — Payments: $65,183
Edward Gomperts, Md, MD
Pediatric Hematology-Oncology — Payments: $65,090